Rural Health
Resources by Topic: Pharmacy and prescription drugs
Health Panel Comment Letter – Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program
Offers comments in response to a December 10, 2024, proposed rule regarding policy and technical changes to the Medicare Advantage program for contract year 2026. Discusses transparency and access to pharmacy services and prescription drugs, network adequacy, notice to providers, and more.
Date: 01/2025
Sponsoring organization: Rural Policy Research Institute Rural Health Panel
view details
Offers comments in response to a December 10, 2024, proposed rule regarding policy and technical changes to the Medicare Advantage program for contract year 2026. Discusses transparency and access to pharmacy services and prescription drugs, network adequacy, notice to providers, and more.
Date: 01/2025
Sponsoring organization: Rural Policy Research Institute Rural Health Panel
view details
January 2025 MedPAC Meeting Transcript
Transcript from the Medicare Payment Advisory Commission's (MedPAC) January 2025 meeting. Covers payment adequacy and updates for physician and other health professional services, hospital inpatient and outpatient services, skilled nursing facility services, home health agency services, inpatient rehabilitation facility services, outpatient dialysis services, and hospice services. Discusses status reports on Medicare Part D, ambulatory surgical centers, and the Medicare Advantage program, as well as policy options for modifying the cost-sharing liability for beneficiaries who receive care at Critical Access Hospitals. Includes rural references and considerations throughout.
Additional links: Reducing Beneficiary Cost-sharing for Outpatient Services at Critical Access Hospitals
Date: 01/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Transcript from the Medicare Payment Advisory Commission's (MedPAC) January 2025 meeting. Covers payment adequacy and updates for physician and other health professional services, hospital inpatient and outpatient services, skilled nursing facility services, home health agency services, inpatient rehabilitation facility services, outpatient dialysis services, and hospice services. Discusses status reports on Medicare Part D, ambulatory surgical centers, and the Medicare Advantage program, as well as policy options for modifying the cost-sharing liability for beneficiaries who receive care at Critical Access Hospitals. Includes rural references and considerations throughout.
Additional links: Reducing Beneficiary Cost-sharing for Outpatient Services at Critical Access Hospitals
Date: 01/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
A Rural-Urban Analysis of Buprenorphine Therapy During and After Pregnancy Among the Commercially Insured
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending
Examines the impact of the Medicare Part D $2,000 cap on out-of-pocket prescription drugs. Provides projected savings according to low-income subsidy (LIS) status, state, and demographic characteristics, including urban, rural-micropolitan, rural-other, or unclassified geographic location.
Date: 01/2025
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Examines the impact of the Medicare Part D $2,000 cap on out-of-pocket prescription drugs. Provides projected savings according to low-income subsidy (LIS) status, state, and demographic characteristics, including urban, rural-micropolitan, rural-other, or unclassified geographic location.
Date: 01/2025
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Combating Antimicrobial Resistance During the COVID-19 Pandemic: Perceived Risks and Protective Practices
Explores the range of factors that impacted efforts to combat antimicrobial resistance (AMR) during the COVID-19 pandemic. Presents findings from an analysis of published scholarly sources and lessons learned from urban and rural healthcare professionals involved in antimicrobial stewardship. Includes rural references and considerations throughout.
Author(s): Casey Sullivan, Cody R. Fisher, Laurin Grabowsky, et al.
Date: 01/2025
Sponsoring organizations: Eastern Research Group, Inc., HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Explores the range of factors that impacted efforts to combat antimicrobial resistance (AMR) during the COVID-19 pandemic. Presents findings from an analysis of published scholarly sources and lessons learned from urban and rural healthcare professionals involved in antimicrobial stewardship. Includes rural references and considerations throughout.
Author(s): Casey Sullivan, Cody R. Fisher, Laurin Grabowsky, et al.
Date: 01/2025
Sponsoring organizations: Eastern Research Group, Inc., HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Number of Licensed Pharmacies by Pennsylvania County as of May 2025
County-level Pennsylvania map showing numbers of licensed pharmacies, and shadings showing counties with fewer than 15, 15-99, and 100 or more pharmacies.
Date: 2025
Sponsoring organization: Center for Rural Pennsylvania
view details
County-level Pennsylvania map showing numbers of licensed pharmacies, and shadings showing counties with fewer than 15, 15-99, and 100 or more pharmacies.
Date: 2025
Sponsoring organization: Center for Rural Pennsylvania
view details
The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care
Examines the climate in rural primary care settings to expand buprenorphine access for opioid use disorder (OUD). Analyzes interview feedback from primary care practitioners in rural Ohio regarding issues such as OUD treatment prioritization, compatibility of buprenorphine prescriptions in primary care settings, and buprenorphine access shortages.
Author(s): Cheyenne Fenstemaker, Elizabeth A. Abrams, Katherine King, et al.
Citation: Journal of General Internal Medicine, 40, 2879-2889
Date: 12/2024
view details
Examines the climate in rural primary care settings to expand buprenorphine access for opioid use disorder (OUD). Analyzes interview feedback from primary care practitioners in rural Ohio regarding issues such as OUD treatment prioritization, compatibility of buprenorphine prescriptions in primary care settings, and buprenorphine access shortages.
Author(s): Cheyenne Fenstemaker, Elizabeth A. Abrams, Katherine King, et al.
Citation: Journal of General Internal Medicine, 40, 2879-2889
Date: 12/2024
view details
Rural Independent Pharmacies Sustainability Strategy
Policy brief discussing unique challenges that threaten the stability of rural independent pharmacies. Offers policy recommendations to support rural independent pharmacies.
Author(s): Sagar Dugani, Vistrit Choudhary, Brian G. Williams
Date: 12/2024
Sponsoring organization: National Rural Health Association
view details
Policy brief discussing unique challenges that threaten the stability of rural independent pharmacies. Offers policy recommendations to support rural independent pharmacies.
Author(s): Sagar Dugani, Vistrit Choudhary, Brian G. Williams
Date: 12/2024
Sponsoring organization: National Rural Health Association
view details
Estimating the Effects of the Medicare $2 Drug List on Part D Enrollees
Discusses the Medicare $2 Drug List (M2DL) Model, which would allow Medicare Part D enrollees to purchase monthly drugs for $2 or less. Provides projected financial impact of the model, such as out of pocket (OOP) costs for individual drugs as well as OOP changes for enrollees, with breakdowns by demographic variables, including urban, rural-micropolitan, rural-other, or unclassified location.
Date: 12/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Discusses the Medicare $2 Drug List (M2DL) Model, which would allow Medicare Part D enrollees to purchase monthly drugs for $2 or less. Provides projected financial impact of the model, such as out of pocket (OOP) costs for individual drugs as well as OOP changes for enrollees, with breakdowns by demographic variables, including urban, rural-micropolitan, rural-other, or unclassified location.
Date: 12/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Understanding MAT Access in the Context of Unused MAT Capacity in the United States: When Increasing Rural MAT Capacity is Not Enough
Examines the factors related to buprenorphine prescriptions to treat opioid use disorder (OUD) and the impacts of the federal DATA waiver to increase provider capacity. Utilizes multiple data sources to describe medication-assisted treatment (MAT) capacity, access, barriers, availability of MAT, and service area need in rural areas.
Author(s): Carolyn Carpenedo Mun, Rachel Zambrano, Eileen Tallman, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 47
Date: 12/2024
view details
Examines the factors related to buprenorphine prescriptions to treat opioid use disorder (OUD) and the impacts of the federal DATA waiver to increase provider capacity. Utilizes multiple data sources to describe medication-assisted treatment (MAT) capacity, access, barriers, availability of MAT, and service area need in rural areas.
Author(s): Carolyn Carpenedo Mun, Rachel Zambrano, Eileen Tallman, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 47
Date: 12/2024
view details